217 related articles for article (PubMed ID: 15656909)
1. Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat.
Candelario-Jalil E; Mhadu NH; González-Falcón A; García-Cabrera M; Muñoz E; León OS; Fiebich BL
J Neuroinflammation; 2005 Jan; 2(1):3. PubMed ID: 15656909
[TBL] [Abstract][Full Text] [Related]
2. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
Candelario-Jalil E; González-Falcón A; García-Cabrera M; León OS; Fiebich BL
Brain Res; 2004 May; 1007(1-2):98-108. PubMed ID: 15064140
[TBL] [Abstract][Full Text] [Related]
3. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion.
Sayeed I; Wali B; Stein DG
Restor Neurol Neurosci; 2007; 25(2):151-9. PubMed ID: 17726274
[TBL] [Abstract][Full Text] [Related]
4. Effects of pyruvate administration on infarct volume and neurological deficits following permanent focal cerebral ischemia in rats.
González-Falcón A; Candelario-Jalil E; García-Cabrera M; León OS
Brain Res; 2003 Nov; 990(1-2):1-7. PubMed ID: 14568323
[TBL] [Abstract][Full Text] [Related]
5. Nimesulide as a promising neuroprotectant in brain ischemia: new experimental evidences.
Candelario-Jalil E
Pharmacol Res; 2008 Apr; 57(4):266-73. PubMed ID: 18439837
[TBL] [Abstract][Full Text] [Related]
6. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
Slivka AP; Murphy EJ
Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
[TBL] [Abstract][Full Text] [Related]
7. Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats.
Candelario-Jalil E; González-Falcón A; García-Cabrera M; León OS; Fiebich BL
J Neurochem; 2007 Feb; 100(4):1108-20. PubMed ID: 17176264
[TBL] [Abstract][Full Text] [Related]
8. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.
Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M
Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669
[TBL] [Abstract][Full Text] [Related]
10. Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats.
Ishrat T; Sayeed I; Atif F; Stein DG
Brain Res; 2009 Feb; 1257():94-101. PubMed ID: 19135987
[TBL] [Abstract][Full Text] [Related]
11. MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model.
Matsuura S; Egi Y; Yuki S; Horikawa T; Satoh H; Akira T
Brain Res; 2011 Sep; 1410():122-31. PubMed ID: 21741620
[TBL] [Abstract][Full Text] [Related]
12. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
13. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia.
Liang S; Pong K; Gonzales C; Chen Y; Ling HP; Mark RJ; Boschelli F; Boschelli DH; Ye F; Barrios Sosa AC; Mansour TS; Frost P; Wood A; Pangalos MN; Zaleska MM
J Pharmacol Exp Ther; 2009 Dec; 331(3):827-35. PubMed ID: 19741150
[TBL] [Abstract][Full Text] [Related]
15. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of prostaglandin E1 and lithium in a rat model of cerebral ischemia.
Han R; Gao B; Sheng R; Zhang LS; Zhang HL; Gu ZL; Qin ZH
Acta Pharmacol Sin; 2008 Oct; 29(10):1141-9. PubMed ID: 18817617
[TBL] [Abstract][Full Text] [Related]
17. Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat.
Zhang L; Zhao H; Zhang X; Chen L; Zhao X; Bai X; Zhang J
Brain Res Bull; 2013 Jul; 96():45-53. PubMed ID: 23644141
[TBL] [Abstract][Full Text] [Related]
18. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection in ischemic stroke--combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia.
Schöller K; Zausinger S; Baethmann A; Schmid-Elsaesser R
Brain Res; 2004 Oct; 1023(2):272-8. PubMed ID: 15374753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]